227 related articles for article (PubMed ID: 29208700)
1. Hypertension-evoked RhoA activity in vascular smooth muscle cells requires RGS5.
Arnold C; Demirel E; Feldner A; Genové G; Zhang H; Sticht C; Wieland T; Hecker M; Heximer S; Korff T
FASEB J; 2018 Apr; 32(4):2021-2035. PubMed ID: 29208700
[TBL] [Abstract][Full Text] [Related]
2. RGS5 Attenuates Baseline Activity of ERK1/2 and Promotes Growth Arrest of Vascular Smooth Muscle Cells.
Demirel E; Arnold C; Garg J; Jäger MA; Sticht C; Li R; Kuk H; Wettschureck N; Hecker M; Korff T
Cells; 2021 Jul; 10(7):. PubMed ID: 34359918
[TBL] [Abstract][Full Text] [Related]
3. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
[TBL] [Abstract][Full Text] [Related]
4. RGS5 promotes arterial growth during arteriogenesis.
Arnold C; Feldner A; Pfisterer L; Hödebeck M; Troidl K; Genové G; Wieland T; Hecker M; Korff T
EMBO Mol Med; 2014 Aug; 6(8):1075-89. PubMed ID: 24972930
[TBL] [Abstract][Full Text] [Related]
5. Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling.
Holobotovskyy V; Manzur M; Tare M; Burchell J; Bolitho E; Viola H; Hool LC; Arnolda LF; McKitrick DJ; Ganss R
Circ Res; 2013 Mar; 112(5):781-91. PubMed ID: 23303165
[TBL] [Abstract][Full Text] [Related]
6. PDGF-dependent regulation of regulator of G protein signaling-5 expression and vascular smooth muscle cell functionality.
Gunaje JJ; Bahrami AJ; Schwartz SM; Daum G; Mahoney WM
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C478-89. PubMed ID: 21593453
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced miR-182-5p regulates vascular smooth muscle cell phenotypic switch by targeting RGS5.
Wang X; Xu X; Zhu Q; Han Y; Zhang W
Cell Biol Int; 2022 Nov; 46(11):1864-1875. PubMed ID: 35946384
[TBL] [Abstract][Full Text] [Related]
8. PPARγ regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity.
Ketsawatsomkron P; Lorca RA; Keen HL; Weatherford ET; Liu X; Pelham CJ; Grobe JL; Faraci FM; England SK; Sigmund CD
Circ Res; 2012 Nov; 111(11):1446-58. PubMed ID: 22962432
[TBL] [Abstract][Full Text] [Related]
9. Keeping the Balance Right: Regulator of G Protein Signaling 5 in Vascular Physiology and Pathology.
Ganss R
Prog Mol Biol Transl Sci; 2015; 133():93-121. PubMed ID: 26123304
[TBL] [Abstract][Full Text] [Related]
10. Genetic ablation of NFAT5/TonEBP in smooth muscle cells impairs flow- and pressure-induced arterial remodeling in mice.
Arnold C; Feldner A; Zappe M; Komljenovic D; De La Torre C; Ruzicka P; Hecker M; Neuhofer W; Korff T
FASEB J; 2019 Mar; 33(3):3364-3377. PubMed ID: 30383452
[TBL] [Abstract][Full Text] [Related]
11. Arterial wall stress controls NFAT5 activity in vascular smooth muscle cells.
Scherer C; Pfisterer L; Wagner AH; Hödebeck M; Cattaruzza M; Hecker M; Korff T
J Am Heart Assoc; 2014 Mar; 3(2):e000626. PubMed ID: 24614757
[TBL] [Abstract][Full Text] [Related]
12. Regulator of G protein signaling 5 marks peripheral arterial smooth muscle cells and is downregulated in atherosclerotic plaque.
Li J; Adams LD; Wang X; Pabon L; Schwartz SM; Sane DC; Geary RL
J Vasc Surg; 2004 Sep; 40(3):519-28. PubMed ID: 15337883
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II Type 1 Receptor Mechanoactivation Involves RGS5 (Regulator of G Protein Signaling 5) in Skeletal Muscle Arteries: Impaired Trafficking of RGS5 in Hypertension.
Hong K; Li M; Nourian Z; Meininger GA; Hill MA
Hypertension; 2017 Dec; 70(6):1264-1272. PubMed ID: 29061726
[TBL] [Abstract][Full Text] [Related]
14. RGS5 maintaining vascular homeostasis is altered by the tumor microenvironment.
Kong P; Wang X; Gao YK; Zhang DD; Huang XF; Song Y; Zhang WD; Guo RJ; Li H; Han M
Biol Direct; 2023 Nov; 18(1):78. PubMed ID: 37986113
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cardiomyocyte signaling by RGS proteins: differential selectivity towards G proteins and susceptibility to regulation.
Hao J; Michalek C; Zhang W; Zhu M; Xu X; Mende U
J Mol Cell Cardiol; 2006 Jul; 41(1):51-61. PubMed ID: 16756988
[TBL] [Abstract][Full Text] [Related]
16. RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy.
Wang X; Adams LD; Pabón LM; Mahoney WM; Beaudry D; Gunaje J; Geary RL; Deblois D; Schwartz SM
J Mol Cell Cardiol; 2008 Mar; 44(3):539-50. PubMed ID: 18207159
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor cAMP response element modulator (Crem) restrains Pdgf-dependent proliferation of vascular smooth muscle cells in mice.
Seidl MD; Steingräber AK; Wolf CT; Sur TM; Hildebrandt I; Witten A; Stoll M; Fischer JW; Schmitz W; Müller FU
Pflugers Arch; 2015 Oct; 467(10):2165-77. PubMed ID: 25425331
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.
Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Benyó Z; Offermanns S; Ruisanchez É; Szabó E; Takáts Z; Bátkai S; Tóth ZE; Hunyady L
Mol Cell Endocrinol; 2015 Mar; 403():46-56. PubMed ID: 25595485
[TBL] [Abstract][Full Text] [Related]
19. G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase.
Takashima S; Sugimoto N; Takuwa N; Okamoto Y; Yoshioka K; Takamura M; Takata S; Kaneko S; Takuwa Y
Cardiovasc Res; 2008 Sep; 79(4):689-97. PubMed ID: 18480127
[TBL] [Abstract][Full Text] [Related]
20. Origin-specific epigenetic program correlates with vascular bed-specific differences in Rgs5 expression.
Zhang H; Gu S; Al-Sabeq B; Wang S; He J; Tam A; Cifelli C; Mathalone N; Tirgari S; Boyd S; Heximer SP
FASEB J; 2012 Jan; 26(1):181-91. PubMed ID: 21965603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
